Auriclosene

N/A

Report date: 2022/11/25 17:28:25
NME

Base Information

Drug NameAuriclosene
Drug Alias NameAuricloseno奥立氯生AgaNase奥利氯新Auriclosenum +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteins inhibitors
TargetsProteins
Therapy Area/IndicationsAcne VulgarisBacteriuriaConjunctivitis, Viral +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesBrazilSri Lanka +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovabay Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalderma R&DNovabay Pharmaceuticals IncAlcon
Active IndicationsN/A
Inactive IndicationsAcne VulgarisBacteriuriaConjunctivitis, Viral +[5] 

Other Information

ATC CodeN/A
Related LinksN/A